-
1
-
-
77954323703
-
Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial
-
Govi S, Dognini GP, Licata G, et al. Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial. Br J Haematol 2010;150:226-9.
-
(2010)
Br J Haematol
, vol.150
, pp. 226-229
-
-
Govi, S.1
Dognini, G.P.2
Licata, G.3
-
2
-
-
68449098158
-
Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells
-
Hayun R, Okun E, Berrebi A, et al. Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells. Leuk Lymphoma 2009;50:625-32.
-
(2009)
Leuk Lymphoma
, vol.50
, pp. 625-632
-
-
Hayun, R.1
Okun, E.2
Berrebi, A.3
-
3
-
-
3142574652
-
Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL
-
Mizunoe S, Kadota J, Tokimatsu I, Kishi K, Nagai H, Nasu M. Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol 2004;4:1201-7.
-
(2004)
Int Immunopharmacol
, vol.4
, pp. 1201-1207
-
-
Mizunoe, S.1
Kadota, J.2
Tokimatsu, I.3
Kishi, K.4
Nagai, H.5
Nasu, M.6
-
4
-
-
77956820901
-
Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin
-
Ishimatsu Y, Mukae H, Matsumoto K, et al. Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest 2010;138:730-3.
-
(2010)
Chest
, vol.138
, pp. 730-733
-
-
Ishimatsu, Y.1
Mukae, H.2
Matsumoto, K.3
-
5
-
-
38949216066
-
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma
-
Niesvizky R, Jayabalan DS, Christos PJ, et al. BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma. Blood 2008;111:1101-9.
-
(2008)
Blood
, vol.111
, pp. 1101-1109
-
-
Niesvizky, R.1
Jayabalan, D.S.2
Christos, P.J.3
-
6
-
-
0037321151
-
Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease
-
Sauter C, Blum S. Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease. Am J Clin Oncol 2003;26:92-4.
-
(2003)
Am J Clin Oncol
, vol.26
, pp. 92-94
-
-
Sauter, C.1
Blum, S.2
-
7
-
-
77957273651
-
Partial regression of duodenal lesions of intestinal follicular lymphoma after antibiotic treatment
-
Yaguchi T, Imaeda H, Kizaki M, et al. Partial regression of duodenal lesions of intestinal follicular lymphoma after antibiotic treatment. Dig Endosc 2010;22:316-8.
-
(2010)
Dig Endosc
, vol.22
, pp. 316-318
-
-
Yaguchi, T.1
Imaeda, H.2
Kizaki, M.3
-
8
-
-
4444326818
-
Follicular lymphoma international prognostic index
-
Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 2004;104:1258-65.
-
(2004)
Blood
, vol.104
, pp. 1258-1265
-
-
Solal-Céligny, P.1
Roy, P.2
Colombat, P.3
-
9
-
-
34347213425
-
Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma
-
Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007;25:2426-33.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2426-2433
-
-
Montoto, S.1
Davies, A.J.2
Matthews, J.3
-
10
-
-
14944374754
-
Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice
-
Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H, Hibi T. Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice. Anticancer Res 2004;24:3723-30.
-
(2004)
Anticancer Res
, vol.24
, pp. 3723-3730
-
-
Ohara, T.1
Morishita, T.2
Suzuki, H.3
Masaoka, T.4
Ishii, H.5
Hibi, T.6
-
11
-
-
0037307173
-
Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive
-
Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003;101:1149-54.
-
(2003)
Blood
, vol.101
, pp. 1149-1154
-
-
Bosga-Bouwer, A.G.1
van Imhoff, G.W.2
Boonstra, R.3
-
12
-
-
9144220128
-
Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma
-
Zhao WL, Daneshpouy ME, Mounier N, et al. Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood 2004;103:695-7.
-
(2004)
Blood
, vol.103
, pp. 695-697
-
-
Zhao, W.L.1
Daneshpouy, M.E.2
Mounier, N.3
|